(Q45948329)

18 December 2017

title

Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trial. (English)

1 reference

18 December 2017

1 reference

1

Amit N Patel

1 reference

18 December 2017

Arshed A Quyyumi

3

object named as

Arshed A Quyyumi

1 reference

18 December 2017

author name string

Timothy D Henry

2

1 reference

18 December 2017

Gary L Schaer

4

1 reference

18 December 2017

R David Anderson

5

1 reference

18 December 2017

Catalin Toma

6

1 reference

18 December 2017

Cara East

7

1 reference

18 December 2017

Ann E Remmers

8

1 reference

18 December 2017

James Goodrich

9

1 reference

18 December 2017

Akshay S Desai

10

1 reference

18 December 2017

David Recker

11

1 reference

18 December 2017

Anthony DeMaria

12

1 reference

18 December 2017

ixCELL-DCM Investigators

13

1 reference

18 December 2017

language of work or name

English

0 references

publication date

5 April 2016

1 reference

18 December 2017

published in

The Lancet

1 reference

18 December 2017

volume

387

1 reference

18 December 2017

issue

10036

1 reference

18 December 2017

page(s)

2412-2421

1 reference

18 December 2017

Prior hospital admission predicts thirty-day hospital readmission for heart failure patients

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930137-4

7 January 2021

National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930137-4

7 January 2021

Cardiomyocyte death: mechanisms and translational implications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930137-4

7 January 2021

New Insights in the Diagnosis and Treatment of Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930137-4

7 January 2021

Stem cell therapy for heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930137-4

7 January 2021

REVIVE Trial: Retrograde Delivery of Autologous Bone Marrow in Patients With Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930137-4

7 January 2021

Intracoronary administration of bone marrow-derived mononuclear cells and arrhythmic events in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930137-4

7 January 2021

Cell therapy for heart disease: Trial sequential analyses of two Cochrane reviews

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930137-4

7 January 2021

Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930137-4

7 January 2021

Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the TOPCARE-CHD Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930137-4

7 January 2021

Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930137-4

7 January 2021

Therapeutic potential of ixmyelocel-T, an expanded autologous multicellular therapy for treatment of ischemic cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930137-4

7 January 2021

The Aastrom experience

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930137-4

7 January 2021

Ixmyelocel-T, an expanded multicellular therapy, contains a unique population of M2-like macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930137-4

7 January 2021

Safety and efficacy of ixmyelocel-T: an expanded, autologous multi-cellular therapy, in dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930137-4

7 January 2021

The ixCELL-DCM Trial: Rationale and Design

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930137-4

7 January 2021

The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930137-4

7 January 2021

Combining mortality and longitudinal measures in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930137-4

7 January 2021

Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930137-4

7 January 2021

Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930137-4

7 January 2021

A Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients With Ischemic or Nonischemic Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930137-4

7 January 2021

RETRACTED: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930137-4

7 January 2021

Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930137-4

7 January 2021

Cardiopoietic Stem Cell Therapy in Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930137-4

7 January 2021

10.1016/S0140-6736(16)30137-4

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017